Literature DB >> 24493874

mTOR controls kidney epithelia in health and disease.

Florian Grahammer1, Nicola Wanner, Tobias B Huber.   

Abstract

Renal epithelial function is the cornerstone of key excretory processes performed by our kidneys. Most of these tasks need to be tightly controlled to keep our internal environment in balance. Recently, the mTOR signalling network emerged as a key pathway controlling renal epithelial cells from the glomerular tuft along the entire nephron. Both mTOR complexes, mTORC1 and mTORC2, regulate such diverse processes as glomerular filtration and the fine tuning of tubular electrolyte balance. Most importantly, dysregulation of mTOR signalling contributes to prevalent kidney diseases like diabetic nephropathy and cystic kidney disease. The following review shall summarize our current knowledge of the renal epithelial mTOR signalling system under physiological and pathophysiological conditions.

Entities:  

Keywords:  ADPKD; diabetic nephropathy; mTOR; podocyte; tubular transport

Mesh:

Substances:

Year:  2014        PMID: 24493874     DOI: 10.1093/ndt/gft491

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  26 in total

1.  AP-2β/KCTD1 Control Distal Nephron Differentiation and Protect against Renal Fibrosis.

Authors:  Alexander G Marneros
Journal:  Dev Cell       Date:  2020-06-17       Impact factor: 12.270

2.  mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.

Authors:  Stéphanie Eid; Suzan Boutary; Kawthar Braych; Ramzi Sabra; Charbel Massaad; Ahmed Hamdy; Awad Rashid; Sarah Moodad; Karen Block; Yves Gorin; Hanna E Abboud; Assaad A Eid
Journal:  Antioxid Redox Signal       Date:  2016-09-12       Impact factor: 8.401

Review 3.  tRNA fragmentation and protein translation dynamics in the course of kidney injury.

Authors:  Iadh Mami; Nicolas Pallet
Journal:  RNA Biol       Date:  2018-02-12       Impact factor: 4.652

Review 4.  The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging.

Authors:  Brian K Kennedy; Dudley W Lamming
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

Review 5.  Roles of mTOR complexes in the kidney: implications for renal disease and transplantation.

Authors:  Daniel Fantus; Natasha M Rogers; Florian Grahammer; Tobias B Huber; Angus W Thomson
Journal:  Nat Rev Nephrol       Date:  2016-08-01       Impact factor: 28.314

Review 6.  Autophagy in renal diseases.

Authors:  Stéphanie De Rechter; Jean-Paul Decuypere; Ekaterina Ivanova; Lambertus P van den Heuvel; Humbert De Smedt; Elena Levtchenko; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2015-07-04       Impact factor: 3.714

7.  mTOR contributes to ER stress and associated apoptosis in renal tubular cells.

Authors:  Guie Dong; Yu Liu; Lei Zhang; Shuang Huang; Han-Fei Ding; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2014-11-26

Review 8.  Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy.

Authors:  C Hu; L Sun; L Xiao; Y Han; X Fu; X Xiong; X Xu; Y Liu; S Yang; F Liu; Y S Kanwar
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

9.  FSGS as an Adaptive Response to Growth-Induced Podocyte Stress.

Authors:  Ryuzoh Nishizono; Masao Kikuchi; Su Q Wang; Mahboob Chowdhury; Viji Nair; John Hartman; Akihiro Fukuda; Larysa Wickman; Jeffrey B Hodgin; Markus Bitzer; Abhijit Naik; Jocelyn Wiggins; Matthias Kretzler; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2017-07-18       Impact factor: 10.121

10.  GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.

Authors:  Honghui Wang; Taro Misaki; Vanessa Taupin; Akiko Eguchi; Pradipta Ghosh; Marilyn G Farquhar
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.